Advice following the issue of the BD Urgent Field Safety Notice MPS-18-1209 regarding the use of BD syringes for intraocular injections.

Following the issue of the BD Urgent Field Safety Notice MPS-18-1209 regarding the use of BD syringes for intraocular injections the interim recommendation is to continue to prepare intraocular injections in the syringes that are currently used including the BD syringes impacted by the FSN, ensuring that the physicians are aware of the risks and are happy to continue to use them.

We are hopeful that an alternative syringe specific for this purpose will become available in due course.

Updated 18th February 2021

Attachments